PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Mar-2023 Participants Dosed on Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa B3C newswire
06-Mar-2023 Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative Evolva Holding SA
03-Mar-2023 Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece Avanzanite Bioscience
03-Mar-2023 Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a. Eckert & Ziegler Strahlen- und Medizintechnik AG
03-Mar-2023 Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends Novotech
03-Mar-2023 ABPI response to government Statutory Scheme rise ABPI
03-Mar-2023 Challenging business year 2022 COLTENE Holding AG
03-Mar-2023 Challenging business year 2022 COLTENE Holding AG
02-Mar-2023 VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation VisionHealth
02-Mar-2023 Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging Pharmapack Europe 2023
02-Mar-2023 ProBioGen’s Growth Strategy Continues Successfully B3C newswire
02-Mar-2023 Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences Sernova Corp.
02-Mar-2023 Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance Cherwell
02-Mar-2023 SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer SiSaf Ltd
02-Mar-2023 CMT Research Foundation (USA) collaborates with Augustine Therapeutics on new therapy against Charcot-Marie-Tooth disease Augustine Therapeutics
02-Mar-2023 Top Pharmaceutical and Life Science Events in March (2023) PharmiWeb.Jobs
02-Mar-2023 Asklepios Kliniken: Group-wide ESG strategy Asklepios Kliniken
02-Mar-2023 MorphoSys Stops Work and Operations on Pre-Clinical Research Programs MorphoSys AG
02-Mar-2023 Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters MorphoSys AG
02-Mar-2023 Santhera Submits Marketing Authorization Application to the UK MHRA for Vamorolone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals